Trident Texofab standalone net profit rises 33.33% in the September 2024 quarter

Net profit of Trident Texofab rose 33.33% to Rs 1.00 crore in the quarter ended September 2024 as against Rs 0.75 crore during the previous quarter ended September 2023. Sales rose 14.01% to Rs 26.45 crore in the quarter ended September 2024 as against Rs 23.20 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	26.45	23.20	14
OPM %	-1.06	5.43	-
PBDT	1.35	1.22	11
PBT	0.94	0.81	16
NP	1.00	0.75	33